Following the introduction of The Health and Safety (Sharp Instruments in Healthcare) Regulations 2013 in May last year there still seems to be some confusion regarding the interpretation of the Regulations and the role of risk assessments in relation to the use of safer sharps and recapping.

Edmund Proffitt, Policy and Public Affairs Director at the BDIA comments, “From May last year all dental practices have to ensure that they comply with the ‘Sharps’ regulations. This means that dental practices must avoid the unnecessary use of sharps and where this is not possible a safer sharp must be used where reasonably practicable”.

He adds, “We believe from the discussions we have had with our members, dental practitioners and the HSE that for the majority of dental activities there will be safer devices available and that risk assessment would deem them reasonably practicable to use.

Therefore, it will be in very limited cases that 'traditional' devices can still be used, and this should be justified by the risk assessment process. Ultimately, it is for a dentist to justify to the courts why they did not use a safety device, and it would be very difficult for a court to agree with the dentist if there was a safety device on the market and others were using them”.  

In terms of the ‘recapping’ of needles, the Regulations clearly state that needles must not be recapped after use unless the employer’s risk assessment has identified that recapping is itself required to prevent a risk (e.g. to reduce the risk of contamination of sterile preparations). In these very limited cases appropriate devices to control the risk of injury to employees must be provided. 

As a result of the constant development of devices and technologies by BDIA members and others it is suggested that if a dentist has decided that it is not reasonably practicable to use a safer sharp in a specific circumstance the decision is regularly reviewed to see if a different or new product is suitable.

For more information please contact Edmund Proffitt on 01494 781183 or This email address is being protected from spambots. You need JavaScript enabled to view it. 

BDIA Showcase takes place between 9th & 11th October 2014 at Excel in London. Further information can be found here www.dentalshowcase.com

Most estate agents know that when the market for dental practices is up, as it is now, the two factors most likely to persuade you to sell through their company are the valuation price and their agency fees. It then follows that each agency you approach will naturally want to come up with the most attractive valuation.

Trusting the judgement of an agency whose sole viewpoint is to convince you to sell your practice through them can lead to lost time, wasted effort and great disappointment.

On the other hand, it would also be unwise to suggest that the judgement of someone who can only provide rigid and cold calculations is the final word. A practice is certainly worth more than its physical assets and patient base, or its monthly revenue minus the running costs.

The best solution, it seems, would be to turn to a company who can offer both marketing expertise and professional accountability; an agency that has been in the business of selling to people and banks for many years, and one that has professional accreditations to top that experience off.

When it comes to the sale of dental practices, there is only one company with such criteria, and that is Christie + Co – the only national firm that specialises in the valuation and sale of dental practices that is also accredited by the Royal Institution of Chartered Surveyors (RICS).

When you deal with a company that offers both years of real estate marketing experience and RICS accreditation, you strike the perfect balance. What the RICS, and companies and surveyors accredited with them ensure, is that when you sell your practice, the basis upon which you determine your pricing stands both the valuation test and the market test.

The valuation test is important because unless you’re selling your practice for cash to someone who doesn’t bother to bring their own surveyors in for another look, it will eventually have to be valued by an independent firm.

The market test is equally significant because the final selling price of your practice also depends of your agency’s knowledge of the market, and their knowledge of your potential buyer.

Selling your practice is essentially passing the trust and welfare of your patients onto the next person, and is naturally something that will be very close to your heart. This is not something that can be tackled with just pure intellect – accurate and impartial calculations also need to be made.

By turning to a company that understands both sides of the dental estate coin, you can be sure that all considerations are covered and your best interests as a seller are paramount.

BIO:

Simon Hughes joined Christie + Co in 1987 and has responsibility for the further expansion of its brokerage services into the Primary Care sectors of dentistry and GP surgery sectors. In the past three years, Christie + Co has advised, valued or sold almost £1 billion worth of businesses. Simon heads up a dedicated team of specialist advisors and agents based in regional locations throughout the UK.

For the last six decades, Eschmann has proven its dedication to the dental and medical community through extensive product research and development.

Its latest innovation comes in the form of the LittleSister SES 3000B Autoclave, which has recently completed a 12-week trial in dental practices and facilities around the UK.

Among these, Dr David Houston, Principal Dentist of The Houston Group of Practices in Somerset says:

“I was pleased with the general design and appearance of the autoclave and found the displays easy to monitor. The inbuilt cycle logger with no trailing leads also ensured that the area remained safe and tidy.

“In addition, the large water tank cut down on the number of refills during a day, and we found the early warning of 'low water' ensured levels were kept constant, reducing the risk of delayed cycles due to insufficient water.

“The large chamber and 10 cassette capacity were certainly a boon to our busy surgery.”

To find out how the LittleSister could streamline your workflow, contact Eschmann today.

For more information please visit www.eschmann.co.uk, or call 01903 753322

Individual Saving Accounts (ISAs) are one of the most popular investment and savings tools being utilised in the UK today.

Over £443 billion has been invested in adult ISAs since their creation in 1999, and since Junior ISAs or JISAs were launched in 2011, they’ve seen more than £557 million in total deposits. With so many UK taxpayers opting in, opening an ISA can’t be a bad decision.

The key benefits of an ISA are its income tax and capital gains tax-free status and its flexibility for either cash or stocks and shares deposits investments. As both children and adults can have multiple ISAs, they are also a great way of helping secure your whole family’s future.

Unlimited transfers can go in and out of ISAs each year with no impact, and they also offer generous savings limits – in 2013/14, the individual allowances for an adult ISA and a JISA are £11,520 and £3,720, respectively.

ISAs are clearly a great investment option – as long as certain things are watched out for.

For example, if you’re moving to another provider, you need to make sure you do not withdraw the funds – rather, complete a transfer form in order to retain your tax-free status.

If you move abroad, you cannot continue putting money into your ISAs as you are no longer a UK resident for tax purposes.

And the ISA’s tax-free benefit is only applicable until death, after which the funds may be subject to inheritance tax.

When investing in an ISA, the key tip to keep in mind is to use as much of your allowance as affordable every year, as these do not carry over. And as with any investment, consulting with a professional before taking any action is always advisable.

For more information about the services available from Lansdell & Rose

please call on 020 7376 9333